A nurse is caring for a client with attention-deficit/hyperactivity disorder (ADHD) who is prescribed methylphenidate (Ritalin). Which symptoms should the nurse monitor as potential side effects? Select all that apply

Attention-deficit/hyperactivity disorder is a neurodevelopmentaldisorder treated primarily with stimulantmedications that enhance dopamineand norepinephrinetransmission in the prefrontal cortex, improving attention and impulse control. Methylphenidate is the most frequently prescribed stimulant for children, with proven efficacy in reducing hyperactivity and improving focus.

Rationale for correct answer:

3.Methylphenidate (Ritalin) is the first-line stimulant for ADHD. It increases synaptic dopamine and norepinephrine, improving attention span and reducing impulsivity. It is widely prescribed in pediatric ADHD due to strong evidence of efficacy and safety.

Rationale for incorrect answers:

1.Lorazepam (Ativan) is a benzodiazepineused for anxiety and acute agitation. It enhances GABA activity, causing sedation. It does not improve attention or hyperactivity, making it inappropriate for ADHD management.

2.Haloperidol (Haldol) is a typical antipsychoticused for schizophrenia and severe agitation. It blocks dopamine receptors, which may worsen attentional deficits. It is not indicated for ADHD and carries risk of extrapyramidal side effects.

4.Methocarbamol (Robaxin) is a muscle relaxantused for musculoskeletal pain. It acts centrally to reduce muscle spasms but has no role in ADHD treatment. It does not affect attention or impulsivity.

Test-taking strategy

• Identify the main condition: ADHD in a pediatric client.
• Recall first-line pharmacologic treatment: stimulants(methylphenidate, amphetamines).
• Rule out distractors:
  • Benzodiazepines treat anxiety, not ADHD.
  • Antipsychotics treat psychosis, not ADHD.
  • Muscle relaxants treat musculoskeletal pain, not ADHD.
• Focus on the option that directly improves dopamineand norepinephrinesignaling in the prefrontal cortex.
• Use elimination methodology: remove drugs unrelated to attentional regulation.
• Correct answer emerges by matching stimulant therapy to ADHD pathophysiology.

Take home points

• Methylphenidate is the most frequently prescribed stimulant for ADHD in children.
• ADHD treatment targets dopamine and norepinephrine pathways to improve attention.
• Benzodiazepines, antipsychotics, and muscle relaxants are not indicated for ADHD.
• Differentiating ADHD pharmacotherapy from other psychiatric and neurologic drugs is essential.

Dextroamphetamine is a stimulantthat enhances dopamineand norepinephrineactivity, improving attention and impulse control in ADHD. However, it frequently causes anorexiaand weight loss due to appetite suppression. Administering the drug after meals helps reduce nutritional impact by allowing adequate intake before appetite suppression begins.

Rationale for correct answer:

3.Administering dextroamphetamine after meals minimizesanorexiaby ensuring the child eats before appetite suppression occurs. This intervention directly addresses imbalanced nutrition and supports growth and weight maintenance in pediatric ADHD clients.

Rationale for incorrect answers:

1.Monitoring output and sleep patterns daily is important for stimulant therapy but does not directly addressnutrition. It helps detect insomnia or urinary changes, yet it fails to correct anorexia-related weight loss.

2.Administering medication with food prevents nausea, not anorexia. Stimulants primarily suppress appetite rather than cause gastrointestinal upset. This intervention does not resolve the nutritional deficit associated with dextroamphetamine.

4.Increasing fiber and fluid intake prevents constipation, a possible side effect of stimulants. While beneficial, it does not address anorexia or weight loss, which are the primary nutritional concerns in this scenario.

Test-taking strategy

• Identify the main issue: imbalanced nutrition due to anorexia from stimulant therapy.
• Recall stimulant side effects: appetite suppression, insomnia, headache, abdominal pain.
• Rule out distractors:
  • Monitoring sleep/output = general care, not nutrition.
  • With food = prevents nausea, not anorexia.
  • Fiber/fluid = prevents constipation, not anorexia.
• Focus on the intervention that directly improves nutritional intake.
• Correct answer emerges by matching anorexia management with timing of medication administration.

Take home points

• Stimulants like dextroamphetamine suppress appetite, leading to anorexia and weight loss.
• Administering medication after meals helps preserve nutritional intake.
• Other interventions address side effects but not anorexia.
• Nurses must monitor growth and weight in children on stimulant therapy.